Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1158810.RAMj03erx8Eh4u1HnPl1pRyFsQbXjzkLYa4xcsu33e23M130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1158810.RAMj03erx8Eh4u1HnPl1pRyFsQbXjzkLYa4xcsu33e23M130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1158810.RAMj03erx8Eh4u1HnPl1pRyFsQbXjzkLYa4xcsu33e23M130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1158810.RAMj03erx8Eh4u1HnPl1pRyFsQbXjzkLYa4xcsu33e23M130_provenance.
- befree-2016 importedOn "2016-02-19" NP1158810.RAMj03erx8Eh4u1HnPl1pRyFsQbXjzkLYa4xcsu33e23M130_provenance.
- NP1158810.RAMj03erx8Eh4u1HnPl1pRyFsQbXjzkLYa4xcsu33e23M130_assertion wasGeneratedBy ECO_0000203 NP1158810.RAMj03erx8Eh4u1HnPl1pRyFsQbXjzkLYa4xcsu33e23M130_provenance.
- NP1158810.RAMj03erx8Eh4u1HnPl1pRyFsQbXjzkLYa4xcsu33e23M130_assertion wasDerivedFrom befree-2016 NP1158810.RAMj03erx8Eh4u1HnPl1pRyFsQbXjzkLYa4xcsu33e23M130_provenance.
- NP1158810.RAMj03erx8Eh4u1HnPl1pRyFsQbXjzkLYa4xcsu33e23M130_assertion SIO_000772 24577808 NP1158810.RAMj03erx8Eh4u1HnPl1pRyFsQbXjzkLYa4xcsu33e23M130_provenance.
- NP1158810.RAMj03erx8Eh4u1HnPl1pRyFsQbXjzkLYa4xcsu33e23M130_assertion evidence source_evidence_literature NP1158810.RAMj03erx8Eh4u1HnPl1pRyFsQbXjzkLYa4xcsu33e23M130_provenance.
- NP1158810.RAMj03erx8Eh4u1HnPl1pRyFsQbXjzkLYa4xcsu33e23M130_assertion description "[In addition to hydroxyurea, second-line cytotoxic chemotherapy agents and hematopoietic cell transplant have been used for aggressive forms of HES and CEL with outcomes reported for limited number of patients.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1158810.RAMj03erx8Eh4u1HnPl1pRyFsQbXjzkLYa4xcsu33e23M130_provenance.